Incannex Healthcare Inc. (NASDAQ:IXHL – Get Free Report)’s share price dropped 1.7% during trading on Thursday . The company traded as low as $2.38 and last traded at $2.38. Approximately 9,511 shares changed hands during trading, a decline of 96% from the average daily volume of 271,512 shares. The stock had previously closed at $2.42.
Incannex Healthcare Stock Performance
The business has a 50-day moving average of $3.76 and a 200 day moving average of $3.18.
Incannex Healthcare (NASDAQ:IXHL – Get Free Report) last issued its earnings results on Wednesday, February 14th. The company reported ($0.33) earnings per share (EPS) for the quarter.
Institutional Investors Weigh In On Incannex Healthcare
Incannex Healthcare Company Profile
Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.
Read More
- Five stocks we like better than Incannex Healthcare
- Most active stocks: Dollar volume vs share volume
- MarketBeat Week in Review – 4/15 – 4/19
- Retail Stocks Investing, Explained
- Comprehensive Analysis of PayPal Stock
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for Incannex Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Incannex Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.